Dr. Sosunmolu Shoyinka is the Chief Medical Officer for the Department of Behavioral Health and Intellectual disAbility Services (DBHIDS). In this role, he works to ensure that policy and programs throughout DBHIDS are aligned with current evidence and best practices to achieve optimal population health outcomes.
Prior to this role, Dr Shoyinka held a number of leadership positions, including director of the Missouri Behavioral Pharmacy Management program and medical director for the Sunflower and Home State Health Plans at Centene Corp. While at Centene, he served as thought leader and subject matter expert on addiction treatment. His accomplishments in that role included co-leading the development of a patent-pending addiction-focused analytic platform, developing addiction-related programs and writing addiction services policy covering more than 12 million lives.
Dr Shoyinka’s clinical experience spans multiple settings. These include telemedicine, academic medicine, private for-profit and state hospitals, forensics, correctional settings, primary care, federally qualified health centers, health homes and community mental health settings. He is board-certified in general adult psychiatry, community and public psychiatry, and addiction medicine. Dr. Shoyinka completed fellowships in psychosomatic medicine and public psychiatry at Yale and Columbia Universities respectively. He completed a fellowship in psychoanalytic psychotherapy at NYU, and holds an MBA from the Kelley School of Business.